Statistiques de base
| CIK | 1296391 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Tengion, Inc.
SEC Filings (Chronological Order)
Cette page fournit une liste complète et chronologique des documents déposés auprès de la SEC, à l'exclusion des documents relatifs à la participation que nous fournissons ailleurs.
| February 11, 2021 |
SC 13G/A 1 tngnq13ga.htm TNGNQ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Tengion, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 88034G208 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desi |
|
| February 16, 2016 |
TNGNQ / Tengion, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| February 12, 2016 |
TNGNQ / Tengion, Inc. / CAPITAL VENTURES INTERNATIONAL - SC 13G/A Passive Investment SC 13G/A 1 a16-372632sc13ga.htm SC 13G/A CUSIP No. 880346109 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. 3)* Tengion, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Se |
|
| October 2, 2015 |
TNGNQ / Tengion, Inc. / CVI Investments, Inc. - SC 13G Passive Investment SC 13G 1 a15-205493sc13g.htm SC 13G CUSIP No. 88034G208 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. )* Tengion, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securiti |
|
| February 17, 2015 |
TNGNQ / Tengion, Inc. / QVT Financial LP - SCHEDULE 13G/A Passive Investment Schedule 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Tengion Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 88034G208 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| February 17, 2015 |
TNGNQ / Tengion, Inc. / RA Capital Management, LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Tengion Inc. (Name of Issuer) Common Stock, par value, $0.001 per share (Title of Class of Securities) 88034G208 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule purs |
|
| February 17, 2015 |
TNGNQ / Tengion, Inc. / Flynn James E Passive Investment SC 13G/A 1 e613314sc13ga-tengion.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 3) * Tengion, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 88034G208 (CUSIP Number) December 31, 2014 |
|
| February 13, 2015 |
TNGNQ / Tengion, Inc. / CAPITAL VENTURES INTERNATIONAL - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. 2)* Tengion, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 880346109 (CUSIP Number) December 31, 2014 (Date of |
|
| February 13, 2015 |
TNGNQ / Tengion, Inc. / CELGENE CORP /DE/ - AMENDMENT NO. 2 TO SCHEDULE 13G Passive Investment SC 13G/A 1 d874034dsc13ga.htm AMENDMENT NO. 2 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* TENGION, INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 88034G109 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this S |
|
| February 11, 2015 |
TNGNQ / Tengion, Inc. / HEALTHCAP IV LP - SCHEDULE 13D/A Activist Investment SC 13D/A 1 d869067dsc13da.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Tengion, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 88034G 10 9 (CUSIP Number) HealthCap IV, L.P. 18 Avenue d’Ouchy Lausanne, V8 CH-1006 With a copy to: Martin J. Waters Wilson Sonsini G |
|
| December 29, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 33 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 33 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| December 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. E |
|
| December 29, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 21 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 21 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| December 29, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 33 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 33 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| December 5, 2014 |
Exhibit 10.1 TENGION, INC. AMENDED AND RESTATED MANAGEMENT SEVERANCE PAY PLAN Instrument of Amendment and Termination WHEREAS, Tengion, Inc. (the “Company”) maintains the Tengion, Inc. Amended and Restated Management Severance Pay Plan (the “Management Severance Plan”), effective as of March 15, 2012; and WHEREAS, the Company as settlor of the Management Severance Plan wishes to amend and terminat |
|
| December 5, 2014 |
Amendment to Offer Letter, as amended, to Timothy Bertram, dated December 4, 2014 EX-10.4 5 ex10-4.htm EXHIBIT 10.4 Exhibit 10.4 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 Timothy A. Bertram c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Offer Letter dated July 28, 2004, as amended December 22, 2008 Dear Tim: This letter agreement (the “Amendment”) amen |
|
| December 5, 2014 |
Amendment to Offer Letter, as amended, to Timothy Bertram, dated December 4, 2014 Exhibit 10.4 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 Timothy A. Bertram c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Offer Letter dated July 28, 2004, as amended December 22, 2008 Dear Tim: This letter agreement (the “Amendment”) amends the offer letter between you an |
|
| December 5, 2014 |
EX-10.1 2 ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 TENGION, INC. AMENDED AND RESTATED MANAGEMENT SEVERANCE PAY PLAN Instrument of Amendment and Termination WHEREAS, Tengion, Inc. (the “Company”) maintains the Tengion, Inc. Amended and Restated Management Severance Pay Plan (the “Management Severance Plan”), effective as of March 15, 2012; and WHEREAS, the Company as settlor of the Management Severance |
|
| December 5, 2014 |
Amendment to Amended Employment Agreement, as amended, with John L. Miclot, dated December 4, 2014 Exhibit 10.2 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 John L. Miclot c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Amended Employment Agreement dated January 20, 2012, as amended December 5, 2013 Dear John: This letter agreement (the “Amendment”) amends the Amended Empl |
|
| December 5, 2014 |
Amendment to Offer Letter, as amended, to Timothy Bertram, dated December 4, 2014 Exhibit 10.4 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 Timothy A. Bertram c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Offer Letter dated July 28, 2004, as amended December 22, 2008 Dear Tim: This letter agreement (the “Amendment”) amends the offer letter between you an |
|
| December 5, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 20 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 20 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| December 5, 2014 |
Amendment to Amended Employment Agreement, as amended, with John L. Miclot, dated December 4, 2014 Exhibit 10.2 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 John L. Miclot c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Amended Employment Agreement dated January 20, 2012, as amended December 5, 2013 Dear John: This letter agreement (the “Amendment”) amends the Amended Empl |
|
| December 5, 2014 |
Amendment to Offer Letter, as amended, to A. Brian Davis, dated December 4, 2014 Exhibit 10.3 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 A. Brian Davis c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Offer Letter dated July 29, 2010, as amended January 1, 2013 Dear Brian: This letter agreement (the “Amendment”) amends the offer letter between you and Te |
|
| December 5, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 32 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 32 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| December 5, 2014 |
Amendment to Amended Employment Agreement, as amended, with John L. Miclot, dated December 4, 2014 Exhibit 10.2 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 John L. Miclot c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Amended Employment Agreement dated January 20, 2012, as amended December 5, 2013 Dear John: This letter agreement (the “Amendment”) amends the Amended Empl |
|
| December 5, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Em |
|
| December 5, 2014 |
Amendment to Offer Letter, as amended, to A. Brian Davis, dated December 4, 2014 Exhibit 10.3 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 A. Brian Davis c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Offer Letter dated July 29, 2010, as amended January 1, 2013 Dear Brian: This letter agreement (the “Amendment”) amends the offer letter between you and Te |
|
| December 5, 2014 |
Amendment to Offer Letter, as amended, to A. Brian Davis, dated December 4, 2014 Exhibit 10.3 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 A. Brian Davis c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Offer Letter dated July 29, 2010, as amended January 1, 2013 Dear Brian: This letter agreement (the “Amendment”) amends the offer letter between you and Te |
|
| December 5, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 32 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 32 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| December 5, 2014 |
Amendment to Offer Letter, as amended, to Timothy Bertram, dated December 4, 2014 Exhibit 10.4 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 Timothy A. Bertram c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Offer Letter dated July 28, 2004, as amended December 22, 2008 Dear Tim: This letter agreement (the “Amendment”) amends the offer letter between you an |
|
| December 5, 2014 |
EX-10.1 2 ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 TENGION, INC. AMENDED AND RESTATED MANAGEMENT SEVERANCE PAY PLAN Instrument of Amendment and Termination WHEREAS, Tengion, Inc. (the “Company”) maintains the Tengion, Inc. Amended and Restated Management Severance Pay Plan (the “Management Severance Plan”), effective as of March 15, 2012; and WHEREAS, the Company as settlor of the Management Severance |
|
| December 5, 2014 |
Amendment to Offer Letter, as amended, to A. Brian Davis, dated December 4, 2014 Exhibit 10.3 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 A. Brian Davis c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Offer Letter dated July 29, 2010, as amended January 1, 2013 Dear Brian: This letter agreement (the “Amendment”) amends the offer letter between you and Te |
|
| December 5, 2014 |
Exhibit 10.1 TENGION, INC. AMENDED AND RESTATED MANAGEMENT SEVERANCE PAY PLAN Instrument of Amendment and Termination WHEREAS, Tengion, Inc. (the “Company”) maintains the Tengion, Inc. Amended and Restated Management Severance Pay Plan (the “Management Severance Plan”), effective as of March 15, 2012; and WHEREAS, the Company as settlor of the Management Severance Plan wishes to amend and terminat |
|
| December 5, 2014 |
Amendment to Amended Employment Agreement, as amended, with John L. Miclot, dated December 4, 2014 Exhibit 10.2 Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 4, 2014 tel: (336) 722-5855 fax: (336) 722-2436 John L. Miclot c/o Tengion Inc. 3929 Westpoint Blvd, Suite G Winston-Salem, NC 27103 Subject: Amendment to Amended Employment Agreement dated January 20, 2012, as amended December 5, 2013 Dear John: This letter agreement (the “Amendment”) amends the Amended Empl |
|
| December 3, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amend |
|
| December 3, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amend |
|
| December 3, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amend |
|
| December 3, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among |
|
| December 3, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among |
|
| December 3, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among |
|
| December 3, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 31 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 31 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| December 3, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Em |
|
| December 3, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among |
|
| December 3, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amend |
|
| December 3, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 31 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 31 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| December 3, 2014 |
2,298,412 Shares Tengion, Inc. 424B3 1 tengion424b3.htm TENGION, INC. FORM 424(B)(3) 333-190196 Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 19 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 19 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part |
|
| November 21, 2014 |
TNGNQ / Tengion, Inc. DEF 14A - - TENGION, INC. FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement þ Definitive Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| November 14, 2014 |
Investor and Media Contact: A. Brian Davis [email protected] 336.201.0155 Tengion Provides Clinical Update and Reports Third Quarter 2014 Financial Results and Cash Position WINSTON-SALEM, NC, November 14, 2014 - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended September 30, 2014. |
|
| November 14, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. E |
|
| November 14, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 29 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 29 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| November 14, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 17 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 17 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| November 14, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 30 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 30 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| November 14, 2014 |
Investor and Media Contact: A. Brian Davis [email protected] 336.201.0155 Tengion Provides Clinical Update and Reports Third Quarter 2014 Financial Results and Cash Position WINSTON-SALEM, NC, November 14, 2014 - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended September 30, 2014. |
|
| November 14, 2014 |
Investor and Media Contact: A. Brian Davis [email protected] 336.201.0155 Tengion Provides Clinical Update and Reports Third Quarter 2014 Financial Results and Cash Position WINSTON-SALEM, NC, November 14, 2014 - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended September 30, 2014. |
|
| November 14, 2014 |
Tengion TENGION, INC. FORM 10-Q (Quarterly Report) tengion10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numb |
|
| November 14, 2014 |
Tengion Provides Clinical Update and Reports Third Quarter 2014 Financial Results and Cash Position Investor and Media Contact: A. Brian Davis [email protected] 336.201.0155 Tengion Provides Clinical Update and Reports Third Quarter 2014 Financial Results and Cash Position WINSTON-SALEM, NC, November 14, 2014 - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended September 30, 2014. |
|
| November 14, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 30 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 30 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| November 14, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 18 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 18 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| November 14, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 29 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 29 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| November 10, 2014 |
TNGNQ / Tengion, Inc. PRE 14A - - TENGION, INC. FORM PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: þ Preliminary Proxy Statement ¨ Definitive Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| October 1, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 28 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 28 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| October 1, 2014 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Emp |
|
| October 1, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 16 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 16 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| October 1, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 28 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 28 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| September 3, 2014 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 September 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended on Februa |
|
| September 3, 2014 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 September 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended on Februa |
|
| September 3, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 27 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 27 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| September 3, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. E |
|
| September 3, 2014 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 September 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Tengion, Inc |
|
| September 3, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 15 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 15 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| September 3, 2014 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 September 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Tengion, Inc |
|
| September 3, 2014 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 September 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended on Februa |
|
| September 3, 2014 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 September 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Tengion, Inc |
|
| September 3, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 27 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 27 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| September 3, 2014 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 September 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Tengion, Inc |
|
| September 3, 2014 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 September 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended on Februa |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-34688 Tengion, In |
|
| August 14, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 26 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 26 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| August 14, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 26 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 26 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| August 14, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 14 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 14 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| July 1, 2014 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Employ |
|
| July 1, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 13 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 13 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| July 1, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 25 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 25 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| July 1, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 25 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 25 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| June 3, 2014 |
Financial Statements and Exhibits, Other Events - TENGION, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Employ |
|
| June 3, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance June 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Teng |
|
| June 3, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance June 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Teng |
|
| June 3, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 24 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 24 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| June 3, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance June 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Teng |
|
| June 3, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance June 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended o |
|
| June 3, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance June 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended o |
|
| June 3, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 12 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 12 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| June 3, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 24 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 24 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| June 3, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance June 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Teng |
|
| June 3, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance June 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended o |
|
| June 3, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance June 2, 2014 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended o |
|
| May 15, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 23 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 23 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| May 15, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 11 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 11 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| May 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-34688 Tengion, I |
|
| May 15, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 23 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 23 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| May 8, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 10 (To Prospectus dated September 18, 2013, as amended) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 10 supplements the prospectus dated September 18, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement |
|
| May 8, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 22 (To Prospectus dated March 28, 2013, as amended) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 22 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 33 |
|
| May 8, 2014 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Employe |
|
| May 8, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 22 (To Prospectus dated March 28, 2013, as amended) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 22 supplements the prospectus dated March 28, 2013 (as supplemented or amended to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-1 |
|
| April 9, 2014 |
- TENGION, INC. FORM POS AM 333-190196 As filed with the Securities and Exchange Commission on April 9, 2014 Registration No. |
|
| April 9, 2014 |
- TENGION, INC. FORM POS AM 333-186687 As filed with the Securities and Exchange Commission on April 9, 2014 Registration No. |
|
| April 9, 2014 |
- TENGION, INC. FORM POS AM 333-184761 As filed with the Securities and Exchange Commission on April 9, 2014 Registration No. |
|
| April 1, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 21 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 21 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| April 1, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 9 (To Prospectus dated September 18, 2013) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 9 supplements the prospectus dated September 18, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-190196). The Pro |
|
| April 1, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 21 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 21 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| April 1, 2014 |
Unregistered Sales of Equity Securities - TENGION, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Emplo |
|
| March 27, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Empl |
|
| March 27, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 20 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 20 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| March 27, 2014 |
Investor and Media Contact: A. Brian Davis [email protected] 336.201.0155 Tengion Reports Fourth Quarter and Full Year 2013 Financial Results WINSTON-SALEM, NC, March 26, 2014 - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2013 and provided a business update. “We made important pro |
|
| March 27, 2014 |
Tengion Reports Fourth Quarter and Full Year 2013 Financial Results Investor and Media Contact: A. Brian Davis [email protected] 336.201.0155 Tengion Reports Fourth Quarter and Full Year 2013 Financial Results WINSTON-SALEM, NC, March 26, 2014 - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2013 and provided a business update. “We made important pro |
|
| March 27, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 20 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 20 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| March 27, 2014 |
Tengion Reports Fourth Quarter and Full Year 2013 Financial Results Investor and Media Contact: A. Brian Davis [email protected] 336.201.0155 Tengion Reports Fourth Quarter and Full Year 2013 Financial Results WINSTON-SALEM, NC, March 26, 2014 - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2013 and provided a business update. “We made important pro |
|
| March 27, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 8 (To Prospectus dated September 18, 2013) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 8 supplements the prospectus dated September 18, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-190196). The Pro |
|
| March 27, 2014 |
Investor and Media Contact: A. Brian Davis [email protected] 336.201.0155 Tengion Reports Fourth Quarter and Full Year 2013 Financial Results WINSTON-SALEM, NC, March 26, 2014 - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2013 and provided a business update. “We made important pro |
|
| March 26, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-34688 Tengion, Inc. ( |
|
| March 26, 2014 |
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Pursuant to Rule 14a-11(c) or rule 14a-12 TENGION, INC. |
|
| March 4, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 19 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 19 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| March 4, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 March 3, 2014 tel: (336) 201-0155 fax: (336) 722-2436 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Ten |
|
| March 4, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 March 3, 2014 tel: (336) 201-0155 fax: (336) 722-2436 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended |
|
| March 4, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 March 3, 2014 tel: (336) 201-0155 fax: (336) 722-2436 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended |
|
| March 4, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 7 (To Prospectus dated September 18, 2013) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 7 supplements the prospectus dated September 18, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-190196). The Pro |
|
| March 4, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 March 3, 2014 tel: (336) 201-0155 fax: (336) 722-2436 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Ten |
|
| March 4, 2014 |
Financial Statements and Exhibits, Other Events - TENGION, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Emplo |
|
| March 4, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 March 3, 2014 tel: (336) 201-0155 fax: (336) 722-2436 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended |
|
| March 4, 2014 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 March 3, 2014 tel: (336) 201-0155 fax: (336) 722-2436 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amended |
|
| March 4, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 19 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 19 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| March 4, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 March 3, 2014 tel: (336) 201-0155 fax: (336) 722-2436 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Ten |
|
| March 4, 2014 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 March 3, 2014 tel: (336) 201-0155 fax: (336) 722-2436 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and among Ten |
|
| February 26, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 18 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 18 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| February 26, 2014 |
CERTIFICATE OF AMENDMENT TO THE FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TENGION, INC. |
|
| February 26, 2014 |
CERTIFICATE OF AMENDMENT TO THE FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TENGION, INC. |
|
| February 26, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 18 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 18 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| February 26, 2014 |
CERTIFICATE OF AMENDMENT TO THE FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TENGION, INC. |
|
| February 26, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 6 (To Prospectus dated September 18, 2013) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 6 supplements the prospectus dated September 18, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-190196). The Pro |
|
| February 26, 2014 |
CERTIFICATE OF AMENDMENT TO THE FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TENGION, INC. |
|
| February 26, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. E |
|
| February 14, 2014 |
TNGNQ / Tengion, Inc. / HEALTHCAP IV LP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Tengion, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 88034G 10 9 (CUSIP Number) HealthCap IV, L.P. 18 Avenue d’Ouchy Lausanne, V8 CH-1006 With a copy to: Martin J. Waters Wilson Sonsini Goodrich & Rosati Professional Corpor |
|
| February 14, 2014 |
TNGNQ / Tengion, Inc. / QVT Financial LP - SCHEDULE 13G AMENDMENT NO. 1 Passive Investment Schedule 13G Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Tengion Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 88034G208 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| February 14, 2014 |
TNGNQ / Tengion, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| February 14, 2014 |
TNGNQ / Tengion, Inc. / RA Capital Management, LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Tengion Inc. (Name of Issuer) Common Stock, par value, $0.001 per share (Title of Class of Securities) 88034G208 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule purs |
|
| February 13, 2014 |
TNGNQ / Tengion, Inc. / CAPITAL VENTURES INTERNATIONAL - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. 1)* Tengion, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 880346109 (CUSIP Number) December 31, 2013 (Date of |
|
| February 12, 2014 |
TNGNQ / Tengion, Inc. / CELGENE CORP /DE/ - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* TENGION, INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 88034G109 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 11, 2014 |
TNGNQ / Tengion, Inc. / OAK MANAGEMENT CORP Passive Investment Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 27, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: o Preliminary Proxy Statement þ Definitive Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| January 27, 2014 |
January 27, 2014 Lisa M. Kahle T +1 (415) 315-6320 F +1 (415) 315-6033 [email protected] Via EDGAR and E-Mail Jeffrey P. Riedler Assistant Director U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Tengion, Inc. Preliminary Proxy Statement on Schedule 14A Filed on January 15, 2014 File No. 001-34688 Dear Mr. Riedler: On behalf of Tengion, Inc. (“Tengion” |
|
| January 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: þ Preliminary Proxy Statement ¨ Definitive Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| January 14, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 17 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 17 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| January 14, 2014 |
Corporate Presentation January 2014 Certain statements in this presentation may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| January 14, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits - TENGION, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Em |
|
| January 14, 2014 |
Corporate Presentation January 2014 Certain statements in this presentation may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| January 14, 2014 |
Corporate Presentation January 2014 Certain statements in this presentation may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| January 14, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 17 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 17 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| January 14, 2014 |
Corporate Presentation January 2014 Certain statements in this presentation may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| January 14, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 5 (To Prospectus dated September 18, 2013) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 5 supplements the prospectus dated September 18, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-190196). The Pro |
|
| January 2, 2014 |
Unregistered Sales of Equity Securities - TENGION, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 2, 2014 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Emp |
|
| January 2, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 16 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 16 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| January 2, 2014 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 16 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 16 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| January 2, 2014 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 4 (To Prospectus dated September 18, 2013) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 4 supplements the prospectus dated September 18, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-190196). The Pro |
|
| December 9, 2013 |
TNGNQ / Tengion, Inc. / Medtronic Inc - SCHEDULE 13D AMENDMENT NO. 2 Activist Investment Schedule 13D Amendment No. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 2)* Tengion, Inc. (Name of Issuer) Common Stock, $.001 par value (Title of Class of |
|
| December 3, 2013 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 3 (To Prospectus dated September 18, 2013) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 3 supplements the prospectus dated September 18, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-190196). The Pro |
|
| December 3, 2013 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and betwee |
|
| December 3, 2013 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and betwee |
|
| December 3, 2013 |
Financial Statements and Exhibits, Other Events - TENGION, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2013 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Em |
|
| December 3, 2013 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 15 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 15 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| December 3, 2013 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and betwee |
|
| December 3, 2013 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amend |
|
| December 3, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 15 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 15 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| December 3, 2013 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amend |
|
| December 3, 2013 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amend |
|
| December 3, 2013 |
Exhibit 99.1 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012 and as amend |
|
| December 3, 2013 |
Exhibit 99.2 A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 December 2, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) tel: (336) 201-0155 fax: (336) 722-2436 [email protected] Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and betwee |
|
| December 2, 2013 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 2 (To Prospectus dated September 18, 2013) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 2 supplements the prospectus dated September 18, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-190196). The Pro |
|
| December 2, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 14 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 14 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| December 2, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 14 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 14 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| December 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-34688 Tengio |
|
| November 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-34688 CUSIP NUMBER 88034G208 (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tr |
|
| October 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2013 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. |
|
| October 2, 2013 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 13 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 13 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| October 2, 2013 |
Celgene Corporation Waiver, dated September 26, 2013 Exhibit 10.1 CELGENE CORPORATION WAIVER This WAIVER, dated as of September 26, 2013, is made by Celgene Corporation (the “Corporation”). Reference is made to those Warrants to Purchase Common Stock of Tengion, Inc., dated as of June 28, 2013, that are held by the Corporation (the “Warrants”). Reference is also made to those Warrants to Purchase Common Stock of Tengion, Inc., dated as of June 28, 2 |
|
| October 2, 2013 |
Celgene Corporation Waiver, dated September 26, 2013 Exhibit 10.1 CELGENE CORPORATION WAIVER This WAIVER, dated as of September 26, 2013, is made by Celgene Corporation (the “Corporation”). Reference is made to those Warrants to Purchase Common Stock of Tengion, Inc., dated as of June 28, 2013, that are held by the Corporation (the “Warrants”). Reference is also made to those Warrants to Purchase Common Stock of Tengion, Inc., dated as of June 28, 2 |
|
| October 2, 2013 |
2,298,412 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-190196 PROSPECTUS SUPPLEMENT NO. 1 (To Prospectus dated September 18, 2013) 2,298,412 Shares Tengion, Inc. This Prospectus Supplement No. 1 supplements the prospectus dated September 18, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-190196). The Pro |
|
| October 2, 2013 |
Celgene Corporation Waiver, dated September 26, 2013 Exhibit 10.1 CELGENE CORPORATION WAIVER This WAIVER, dated as of September 26, 2013, is made by Celgene Corporation (the “Corporation”). Reference is made to those Warrants to Purchase Common Stock of Tengion, Inc., dated as of June 28, 2013, that are held by the Corporation (the “Warrants”). Reference is also made to those Warrants to Purchase Common Stock of Tengion, Inc., dated as of June 28, 2 |
|
| October 2, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 13 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 13 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| October 2, 2013 |
Celgene Corporation Waiver, dated September 26, 2013 Exhibit 10.1 CELGENE CORPORATION WAIVER This WAIVER, dated as of September 26, 2013, is made by Celgene Corporation (the “Corporation”). Reference is made to those Warrants to Purchase Common Stock of Tengion, Inc., dated as of June 28, 2013, that are held by the Corporation (the “Warrants”). Reference is also made to those Warrants to Purchase Common Stock of Tengion, Inc., dated as of June 28, 2 |
|
| September 16, 2013 |
September 16, 2013 VIA EDGAR TRANSMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| August 30, 2013 |
Lisa M. Kahle T +1 (415) 315-6320 F +1 (415) 315-6033 [email protected] August 30, 2013 Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, DC 20549 Attn: Jeffrey P. Riedler Re: Tengion, Inc. Registration Statement on Form S-1 Filed July 26, 2013 File No. 333-190196 Dear Mr. Riedler: On behalf of Tengion, Inc. (the “Company”), we are responding |
|
| August 30, 2013 |
As filed with the Securities and Exchange Commission on August 30, 2013 Registration No. |
|
| August 21, 2013 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] August 20, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012, as amended on February 14 |
|
| August 21, 2013 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] August 20, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012, as amended on February 14 |
|
| August 21, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 12 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 12 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| August 21, 2013 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] August 20, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and between Tengion, Inc |
|
| August 21, 2013 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] August 20, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated October 2, 2012, as amended on February 14 |
|
| August 21, 2013 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] August 20, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and between Tengion, Inc |
|
| August 21, 2013 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 12 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 12 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| August 21, 2013 |
Financial Statements and Exhibits, Other Events - TENGION, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2013 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Emp |
|
| August 21, 2013 |
A. Brian Davis Chief Financial Officer Senior Vice President, Finance Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem, NC 27103 tel: (336) 201-0155 fax: (336) 722-2436 [email protected] August 20, 2013 Re: Notice of Intent to Issue Stock for Interest Payment (via e-mail) Dear Lenders, Pursuant to Section 2.9 of the Facility Agreement dated June 28, 2013, by and between Tengion, Inc |
|
| August 15, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 11 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 11 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| August 15, 2013 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 11 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 11 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| August 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-34688 Tengion, Inc. (Exac |
|
| August 8, 2013 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 10 (To Prospectus dated March 28, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 10 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospect |
|
| August 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2013 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Empl |
|
| August 8, 2013 |
Press Release Tengion Announces Promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance WINSTON-SALEM, N.C., Aug. 7, 2013 /PRNewswire/ - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance. Mr. Davis has served as Chief Financial Officer of Ten |
|
| August 8, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 10 (To Prospectus dated March 28, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 10 supplements the prospectus dated March 28, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus |
|
| August 8, 2013 |
Press Release, dated August 7, 2013 Press Release Tengion Announces Promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance WINSTON-SALEM, N.C., Aug. 7, 2013 /PRNewswire/ - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance. Mr. Davis has served as Chief Financial Officer of Ten |
|
| August 8, 2013 |
Press Release Tengion Announces Promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance WINSTON-SALEM, N.C., Aug. 7, 2013 /PRNewswire/ - Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance. Mr. Davis has served as Chief Financial Officer of Ten |
|
| July 26, 2013 |
Registration Statement - TENGION, INC. FORM S-1 As filed with the Securities and Exchange Commission on July 26, 2013 Registration No. |
|
| July 19, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 9 (To Prospectus dated March 26, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 9 supplements the prospectus dated March 26, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospectus |
|
| July 19, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-184761 PROSPECTUS SUPPLEMENT NO. 9 (To Prospectus dated March 26, 2013) 592,000 Shares Tengion, Inc. This Prospectus Supplement No. 9 supplements the prospectus dated March 26, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-184761). The Prospectus an |
|
| July 19, 2013 |
Submission of Matters to a Vote of Security Holders 8-K 1 tengion8k.htm TENGION, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2013 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (S |
|
| July 12, 2013 |
TNGNQ / Tengion, Inc. / RA CAPITAL MANAGEMENT, L.P. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Tengion Inc. (Name of Issuer) Common Stock, par value, $0.001 per share (Title of Class of Securities) 88034G208 (CUSIP Number) June 28, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t |
|
| July 8, 2013 |
TNGNQ / Tengion, Inc. / QVT Financial LP - SCHEDULE 13G Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Tengion Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 88034G208 (CUSIP Number) June 28, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| July 8, 2013 |
TNGNQ / Tengion, Inc. / CAPITAL VENTURES INTERNATIONAL - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2. (Amendment No. )* Tengion, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 880346109 (CUSIP Number) June 28, 2013 (Date of Even |
|
| July 5, 2013 |
Form of Warrants issued to various investors on June 28, 2013 Exhibit 4.2 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (I) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS S |
|
| July 5, 2013 |
Form of Senior Secured Convertible Notes issued to various investors on June 28, 2013 Exhibit 4.1 THIS NOTE IS BEING ISSUED WITH ORIGINAL ISSUE DISCOUNT (“OID”), IN THE AMOUNT TO BE DETERMINED BY THE COMPANY AND WHICH WILL BE PROVIDED TO EACH HOLDER IN ACCORDANCE WITH APPLICABLE REGULATIONS. THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSF |
|
| July 5, 2013 |
Exhibit 10.6 COLLABORATION AND OPTION AGREEMENT by and between TENGION, INC., CELGENE CORPORATION and CELGENE EUROPEAN INVESTMENT COMPANY LLC June 28, 2013 COLLABORATION AND OPTION AGREEMENT This Collaboration and Option Agreement (this “Agreement”) dated the 28th day of June, 2013 (the “Effective Date”) is by and among Tengion, Inc., a Delaware corporation having its principal office at 3929 West |
|
| July 5, 2013 |
Exhibit 10.5 AMENDMENT, WAIVER AND CONSENT AGREEMENT This Amendment, Waiver and Consent Agreement (this “Agreement”) is entered into this 28th day of June, 2013, by and among Tengion, Inc., a Delaware corporation (the “Company”), and each party identified on the signature pages hereto (the “Investors”). RECITALS A. The Company and the Investors entered into that certain Securities Purchase Agreeme |
|
| July 5, 2013 |
Facility Agreement by and among Tengion, Inc. and the lenders party thereto, dated June 28, 2013 Exhibit 10.2 FACILITY AGREEMENT FACILITY AGREEMENT (this “Agreement”), dated as of June 28, 2013, between Tengion, Inc., a Delaware corporation (the “Borrower”), and the lenders set forth on Schedule 1 attached hereto (the “Lenders” and, together with the Borrower, the “Parties”). W I T N E S S E T H: WHEREAS, the Borrower wishes to borrow from the Lenders $18,576,000.00 for the purpose described |
|
| July 5, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2013 Tengion, Inc. (Exact name of registrant as specified in its charter) 001-34688 (Commission File Number) Delaware 20-0214813 (State or other jurisdiction of (I.R.S. Emplo |
|
| July 5, 2013 |
Press Release, dated June 28, 2013 Exhibit 99.1 Investor and Media Contact: Brian Davis [email protected] 336.201.0155 Tengion Announces Transactions Totaling $33.6 Million to Advance its Organ Regeneration PlatformTM $15 Million Strategic Investment from Celgene Corporation and $18.6 Million Senior Secured Convertible Note Financing with New and Existing Investors WINSTON-SALEM, NC, July 1, 2013 - Tengion, Inc. (OTCQB: TNGN) |
|
| July 5, 2013 |
Form of Warrants issued to Celgene Corporation on June 28, 2013 Exhibit 4.3 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (I) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS S |
|
| July 5, 2013 |
Exhibit 10.7 RIGHT OF FIRST NEGOTIATION AGREEMENT This Right of First Negotiation Agreement (this “Agreement”), dated June 28, 2013, is made by and among Tengion, Inc., a Delaware corporation, with a principal address at 3929 Westpoint Boulevard, Suite G, Winston-Salem, NC 27103 (“Tengion”) and Celgene Corporation, a Delaware corporation with a principal address at 86 Morris Avenue, Summit, New Je |
|
| July 5, 2013 |
Exhibit 10.5 AMENDMENT, WAIVER AND CONSENT AGREEMENT This Amendment, Waiver and Consent Agreement (this “Agreement”) is entered into this 28th day of June, 2013, by and among Tengion, Inc., a Delaware corporation (the “Company”), and each party identified on the signature pages hereto (the “Investors”). RECITALS A. The Company and the Investors entered into that certain Securities Purchase Agreeme |
|
| July 5, 2013 |
Security Agreement by and among Tengion, Inc. and the secured parties thereto, dated June 28, 2013 Exhibit 10.3 SECURITY AGREEMENT This Security Agreement (this “Agreement”), dated as of June 28, 2013, is entered into between TENGION, Inc. (“Obligor”) in favor of the parties identified as secured parties on the signature pages of this Agreement (together, the “Secured Party”). W I T N E S S E T H: WHEREAS, Obligor has entered into a Facility Agreement, dated as of the date hereof (the “Facility |
|
| July 5, 2013 |
Exhibit 10.7 RIGHT OF FIRST NEGOTIATION AGREEMENT This Right of First Negotiation Agreement (this “Agreement”), dated June 28, 2013, is made by and among Tengion, Inc., a Delaware corporation, with a principal address at 3929 Westpoint Boulevard, Suite G, Winston-Salem, NC 27103 (“Tengion”) and Celgene Corporation, a Delaware corporation with a principal address at 86 Morris Avenue, Summit, New Je |
|
| July 5, 2013 |
Exhibit 10.5 AMENDMENT, WAIVER AND CONSENT AGREEMENT This Amendment, Waiver and Consent Agreement (this “Agreement”) is entered into this 28th day of June, 2013, by and among Tengion, Inc., a Delaware corporation (the “Company”), and each party identified on the signature pages hereto (the “Investors”). RECITALS A. The Company and the Investors entered into that certain Securities Purchase Agreeme |
|
| July 5, 2013 |
Form of Warrants issued to various investors on June 28, 2013 Exhibit 4.2 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (I) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS S |
|
| July 5, 2013 |
Form of Senior Secured Convertible Notes issued to various investors on June 28, 2013 Exhibit 4.1 THIS NOTE IS BEING ISSUED WITH ORIGINAL ISSUE DISCOUNT (“OID”), IN THE AMOUNT TO BE DETERMINED BY THE COMPANY AND WHICH WILL BE PROVIDED TO EACH HOLDER IN ACCORDANCE WITH APPLICABLE REGULATIONS. THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSF |
|
| July 5, 2013 |
27,891,407 Shares Tengion, Inc. Filed Pursuant to Rule 424(b)(3) Registration No. 333-186687 PROSPECTUS SUPPLEMENT NO. 8 (To Prospectus dated March 26, 2013) 27,891,407 Shares Tengion, Inc. This Prospectus Supplement No. 8 supplements the prospectus dated March 26, 2013 (as supplemented to date, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration Statement No. 333-186687). The Prospectus |
|
| July 5, 2013 |
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 28, 2013 by and among Tengion, Inc., a Delaware corporation (the “Company”), those persons set forth on Schedule 1 to the Facility Agreement (as defined below) and Celgene Corporation (“Celgene”) (each individually, an “Investor” and together, the “Investors”). WHEREAS: A. In connection wi |
|
| July 5, 2013 |
Exhibit 99.1 Investor and Media Contact: Brian Davis [email protected] 336.201.0155 Tengion Announces Transactions Totaling $33.6 Million to Advance its Organ Regeneration PlatformTM $15 Million Strategic Investment from Celgene Corporation and $18.6 Million Senior Secured Convertible Note Financing with New and Existing Investors WINSTON-SALEM, NC, July 1, 2013 - Tengion, Inc. (OTCQB: TNGN) |
|
| July 5, 2013 |
Form of Warrants issued to Celgene Corporation on June 28, 2013 Exhibit 4.3 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (I) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS S |
|
| July 5, 2013 |
Form of Warrants issued to various investors on June 28, 2013 Exhibit 4.2 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (I) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS S |
|
| July 5, 2013 |
Facility Agreement by and among Tengion, Inc. and the lenders party thereto, dated June 28, 2013 Exhibit 10.2 FACILITY AGREEMENT FACILITY AGREEMENT (this “Agreement”), dated as of June 28, 2013, between Tengion, Inc., a Delaware corporation (the “Borrower”), and the lenders set forth on Schedule 1 attached hereto (the “Lenders” and, together with the Borrower, the “Parties”). W I T N E S S E T H: WHEREAS, the Borrower wishes to borrow from the Lenders $18,576,000.00 for the purpose described |
|
| July 5, 2013 |
Press Release, dated June 28, 2013 Exhibit 99.1 Investor and Media Contact: Brian Davis [email protected] 336.201.0155 Tengion Announces Transactions Totaling $33.6 Million to Advance its Organ Regeneration PlatformTM $15 Million Strategic Investment from Celgene Corporation and $18.6 Million Senior Secured Convertible Note Financing with New and Existing Investors WINSTON-SALEM, NC, July 1, 2013 - Tengion, Inc. (OTCQB: TNGN) |
|
| July 5, 2013 |
Exhibit 10.6 COLLABORATION AND OPTION AGREEMENT by and between TENGION, INC., CELGENE CORPORATION and CELGENE EUROPEAN INVESTMENT COMPANY LLC June 28, 2013 COLLABORATION AND OPTION AGREEMENT This Collaboration and Option Agreement (this “Agreement”) dated the 28th day of June, 2013 (the “Effective Date”) is by and among Tengion, Inc., a Delaware corporation having its principal office at 3929 West |
|
| July 5, 2013 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of June 28, 2013 by and among Tengion, Inc. a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). RECITALS A. The Company and the Purchasers are exec |
|
| July 5, 2013 |
Form of Senior Secured Convertible Notes issued to various investors on June 28, 2013 Exhibit 4.1 THIS NOTE IS BEING ISSUED WITH ORIGINAL ISSUE DISCOUNT (“OID”), IN THE AMOUNT TO BE DETERMINED BY THE COMPANY AND WHICH WILL BE PROVIDED TO EACH HOLDER IN ACCORDANCE WITH APPLICABLE REGULATIONS. THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSF |
|
| July 5, 2013 |
Exhibit 10.7 RIGHT OF FIRST NEGOTIATION AGREEMENT This Right of First Negotiation Agreement (this “Agreement”), dated June 28, 2013, is made by and among Tengion, Inc., a Delaware corporation, with a principal address at 3929 Westpoint Boulevard, Suite G, Winston-Salem, NC 27103 (“Tengion”) and Celgene Corporation, a Delaware corporation with a principal address at 86 Morris Avenue, Summit, New Je |
|
| July 5, 2013 |
Exhibit 10.6 COLLABORATION AND OPTION AGREEMENT by and between TENGION, INC., CELGENE CORPORATION and CELGENE EUROPEAN INVESTMENT COMPANY LLC June 28, 2013 COLLABORATION AND OPTION AGREEMENT This Collaboration and Option Agreement (this “Agreement”) dated the 28th day of June, 2013 (the “Effective Date”) is by and among Tengion, Inc., a Delaware corporation having its principal office at 3929 West |
|
| July 5, 2013 |
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 28, 2013 by and among Tengion, Inc., a Delaware corporation (the “Company”), those persons set forth on Schedule 1 to the Facility Agreement (as defined below) and Celgene Corporation (“Celgene”) (each individually, an “Investor” and together, the “Investors”). WHEREAS: A. In connection wi |
|
| July 5, 2013 |
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 28, 2013 by and among Tengion, Inc., a Delaware corporation (the “Company”), those persons set forth on Schedule 1 to the Facility Agreement (as defined below) and Celgene Corporation (“Celgene”) (each individually, an “Investor” and together, the “Investors”). WHEREAS: A. In connection wi |
|
| July 5, 2013 |
Security Agreement by and among Tengion, Inc. and the secured parties thereto, dated June 28, 2013 Exhibit 10.3 SECURITY AGREEMENT This Security Agreement (this “Agreement”), dated as of June 28, 2013, is entered into between TENGION, Inc. (“Obligor”) in favor of the parties identified as secured parties on the signature pages of this Agreement (together, the “Secured Party”). W I T N E S S E T H: WHEREAS, Obligor has entered into a Facility Agreement, dated as of the date hereof (the “Facility |
|
| July 5, 2013 |
Facility Agreement by and among Tengion, Inc. and the lenders party thereto, dated June 28, 2013 Exhibit 10.2 FACILITY AGREEMENT FACILITY AGREEMENT (this “Agreement”), dated as of June 28, 2013, between Tengion, Inc., a Delaware corporation (the “Borrower”), and the lenders set forth on Schedule 1 attached hereto (the “Lenders” and, together with the Borrower, the “Parties”). W I T N E S S E T H: WHEREAS, the Borrower wishes to borrow from the Lenders $18,576,000.00 for the purpose described |
|
| July 5, 2013 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of June 28, 2013 by and among Tengion, Inc. a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). RECITALS A. The Company and the Purchasers are exec |
|
| July 5, 2013 |
Form of Warrants issued to Celgene Corporation on June 28, 2013 Exhibit 4.3 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (I) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS S |
